NEJM at ESMO - Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMe2411485. Online ahead of print.
No abstract available

Publication types

  • Editorial